Perinorm Tablet contains the active component Metoclopramide. It is commonly used to treat gastrointestinal disorders. It works by increasing muscle contractions in the upper digestive tract, which helps speed up food movement and reduce nausea and vomiting. This benefit is particularly relevant for individuals with gastroparesis, a condition characterized by delayed stomach emptying. This medication is primarily eliminated from the body through the kidneys. In individuals with severe renal impairment, dosage adjustments are. Abrupt discontinuation of Perinorm Tablet after prolonged use may lead to withdrawal symptoms such as nausea, vomiting, anxiety, and agitation. Consult your healthcare provider for guidance on tapering the medication if necessary.

If a person has a known hypersensitivity or allergy to Perinorm Tablet or any of its ingredients, its use should be avoided. It should not be used if there is a known or suspected blockage or perforation in the gastrointestinal tract. The medication could potentially worsen the condition or lead to complications. It should generally be avoided in individuals with Parkinson's disease unless a healthcare professional carefully evaluates the potential benefits.

• Gastroparesis
• Nausea and vomiting
• Gastroesophageal reflux disease (Acid reflux and heartburn)

Perinorm Tablet's therapeutic benefits include improved gastric emptying, relief from nausea and vomiting, and enhanced gastrointestinal motility, that leads to digestive function and symptom management in relevant gastrointestinal disorders.

Inform the doctor about your medicines, including prescription, over-the-counter, nutritional or vitamin supplements, and herbal products. Certain medications may interact with Perinorm Tablet, reducing effectiveness by causing undesirable side effects.

• Stored at controlled room temperature, between 20°C to 25°C (68°F to 77°F).
• Keep away from moisture, heat, and light.
• It should not be frozen.
• Keep away from children and pets.

To use Perinorm Tablet effectively, it is important to follow the instructions provided by your healthcare provider or the medication packaging. This medication is typically taken orally before meals, either in tablet or liquid form, as directed by your doctor. The dosage and frequency will depend on the specific condition being treated. It is crucial to adhere to the prescribed dose and schedule and not exceed the recommended duration of use.

Perinorm Tablet cause some side effects like all medications, although not everyone will experience them. 

Serious:

• Allergic reactions such as rash, itching, or swelling of the face, tongue, or throat
• Severe dizziness or lightheadedness
• Involuntary muscle contractions
• Parkinson's disease (tremors, stiffness, and slow movements)
• Altered mental status
• Seizures

Common:

• Drowsiness
• Fatigue
• Restlessness
• Dizziness
• Headache
• Nausea
• Diarrhea
• Abdominal pain or discomfort
• Changes in vision
• Insomnia (difficulty sleeping)

It is important to inform your healthcare provider about any existing medical conditions, including liver or kidney impairment, epilepsy, or cardiovascular diseases. Close monitoring is needed in elderly patients and those with a history of movement disorders. Some individuals may experience hypersensitivity reactions to Perinorm Tablet, including allergic reactions. Seek immediate medical attention if you develop symptoms such as rash, itching, swelling, or difficulty breathing. It should be used cautiously in individuals with a history of cardiovascular disease, arrhythmias, or those taking other medications that can affect heart rhythm. Pregnant or breastfeeding individuals should seek medical advice before using it.  This medication should be used cautiously in children, as they may be more susceptible to certain side effects, such as movement disorders. The benefits and risks should be carefully evaluated in pediatric patients.

1. Hameln pharma Ltd, Electronic medicines compendium (EMC), [Revised on 26 Jan 2022], [Accessed on 9th June 2023], https://www.medicines.org.uk/emc/product/6283/pil#gref
2. ANI Pharmaceuticals, Inc, US Food and Drug Administration, [Revised on August 2017],[Accessed on 9th June 2023], https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/017854s062lbl.pdf